Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 4/20 | 0.42 |
| ▸ | GABBR1 | Q9UBS5 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3554163 | 1.00 | KMT2A (0.46) | KMT2ASMN1; SMN2SLC7A5ANPEPCA2 | |
| SCHEMBL2765505 | 1.00 | KMT2A (0.46) | KMT2ASMN1; SMN2SLC7A5ANPEPCA2 | |
| Bicarbonate SCHEMBL15743197 | 0.98 | KMT2A (0.45) | KMT2ASMN1; SMN2SLC7A5ANPEPCA2 | |
| SCHEMBL8407301 | 0.83 | CA2 (0.47) | SLC7A5ANPEPCA2CYP2C9CYP2D6 | |
| SCHEMBL27735171 | 0.83 | CA2 (0.47) | SLC7A5ANPEPCA2CYP2C9CYP2D6 | |
| SCHEMBL2303463 | 0.83 | SMN1; SMN2 (0.54) | KMT2ASMN1; SMN2ANPEPCYP2C9MEN1 | |
| SCHEMBL7104404 | 0.83 | SMN1; SMN2 (0.54) | KMT2ASMN1; SMN2ANPEPCYP2C9MEN1 | |
| SCHEMBL59840 | 0.83 | GABBR2 (0.59) | KMT2ASMN1; SMN2CYP2D6CYP2C19GABBR2 | |
| SCHEMBL288753 | 0.83 | GABBR2 (0.59) | KMT2ASMN1; SMN2CYP2D6CYP2C19GABBR2 | |
| SCHEMBL123765 | 0.83 | GABBR2 (0.59) | KMT2ASMN1; SMN2CYP2D6CYP2C19GABBR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118125936-A | N-acyl ethanolamide derivative, preparation method and application thereof | 南京清普生物科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| WO-2023128791-A1 | COMBINATION DRUG FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ЦЕНТР РАННЕЙ ДИАГНОСТИКИ НЕЙРОДЕГЕНЕРАТИВНЫХ ЗАБОЛЕВАНИЙ" | 2023-07-06 | — | — | WO | claimed |
| CN-116217422-A | Method for preparing amino acid with high added value by using lignin in papermaking wastewater | 浙江师范大学 | 2023-06-06 | — | — | CN | claimed |
| CN-113651946-B | Epoxy resin curing agent and preparation method and application thereof | 万华化学集团股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-113151348-B | Application of rice OsTAM1 gene in regulation and control of plant insect resistance | 华南农业大学 | 2023-01-10 | — | — | CN | claimed |
| CN-114796520-A | anti-CD 74 antibody conjugates, compositions comprising anti-CD 74 antibody conjugates, and methods of use of anti-CD 74 antibody conjugates | 苏特罗生物制药公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114805528-A | Cystine knot scaffold platform | 豪夫迈·罗氏有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113136392-B | Application of rice OsTAM1 gene in regulation of plant leaf angle | 华南农业大学 | 2022-06-28 | — | — | CN | claimed |
| CN-114634958-A | Method for insertion of unnatural amino acids using cell-free protein synthesis system | 清华大学 | 2022-06-17 | — | — | CN | claimed |
| CN-113651946-A | Epoxy resin curing agent and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-113151348-A | Application of rice OsTAM1 gene in regulation and control of plant insect resistance | 华南农业大学 | 2021-07-23 | — | — | CN | claimed |
| CN-113136392-A | Application of rice OsTAM1 gene in regulation and control of plant leaf included angle | 华南农业大学 | 2021-07-20 | — | — | CN | claimed |
| CN-109251708-B | Energy-saving and environment-friendly adhesive | 深圳市宏进科技有限公司 | 2021-04-02 | — | — | CN | claimed |
| CN-107382761-B | A kind of synthetic method that 3- amino -3- (4- hydroxy phenyl) propionic acid is split | 滨海吉尔多肽有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-107382761-A | The synthetic method that a kind of 3 amino 3 (4 hydroxy phenyl) propionic acid are split | 滨海吉尔多肽有限公司 | 2017-11-24 | — | — | CN | claimed |
| CN-122075714-A | Liver cirrhosis treatment and liver cancer prevention method based on cMeta activation | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260103488-A1 | ACTIVATING AGENTS | INTERK PEPTIDE THERAPEUTICS LIMITED (AU) | 2026-04-16 | — | — | US | disclosed |
| EP-0690847-A1 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994022834-A1 | HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994022835-A2 | HETEROCYCLIC COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | ZENECA LIMITED (GB) | 1994-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103488-A1 | ACTIVATING AGENTS | LCK, LTK, CD14 | KMT2A 1467/4885SMN1; SMN2 3996/4885SLC7A5 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.